Marker TherapeuticsMRKR
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 27 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q2 2024. 4 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($3.0M), Aisling Capital Management LP ($886K) and Vanguard Group Inc. ($686K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $154K |
| Exits | 4 | $388K |
All 13F filers, Q2 2024 → Q3 2024: 63,588 shares bought and 73,011 shares sold, net −9,423 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| NEA Management Company, LLC | 0.16% | No change | 1,071,428 | $3.0M |
| Aisling Capital Management LP | 0.34% | No change | 314,286 | $886K |
| Vanguard Group Inc. | 0.00% | Add +2.0% | 243,122 | $686K |
| Geode Capital Management, LLC | 0.00% | Add +4.9% | 71,561 | $202K |
| Renaissance Technologies | 0.00% | Add +2.3% | 39,750 | $112K |
| Northern Trust Corp. | 0.00% | Reduce -2.8% | 32,453 | $92K |
| State Street Corp. | 0.00% | No change | 20,948 | $59K |
| Dimensional Fund Advisors LP | 0.00% | No change | 20,278 | $57K |
| Invst, LLC | 0.01% | New | 20,000 | $56K |
| UBS Group AG | 0.00% | New | 19,104 | $54K |
| BlackRock, Inc. | 0.00% | — | 19,006 | $54K |
| Creative Planning | 0.00% | No change | 17,312 | $49K |
| Matrix Asset Advisors Inc. | 0.00% | No change | 15,000 | $42K |
| Citadel Advisors | 0.00% | New | 13,032 | $37K |
| Osaic Holdings, Inc. | 0.00% | No change | 7,085 | $20K |
| Morgan Stanley | 0.00% | No change | 3,408 | $10K |
| Bank of America Corp. | 0.00% | Add +0.0% | 2,617 | $7K |
| ADAR1 Capital Management, LLC | 0.00% | New | 2,432 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -19.2% | 1,508 | $4K |
| Riggs Asset Managment Co. Inc. | 0.00% | Reduce -14.3% | 1,200 | $3K |
| US Bancorp \de | 0.00% | No change | 839 | $2K |
| Wells Fargo & Company | 0.00% | No change | 232 | $654 |
| Group One Trading LLC | 0.00% | No change | 178 | $502 |
| Hilltop National Bank | 0.00% | No change | 73 | $206 |
| JPMorgan Chase & Co. | 0.00% | No change | 38 | $107 |
| Versant Capital Management, Inc | 0.00% | No change | 15 | $42 |
| FMR LLC | 0.00% | No change | 12 | $34 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.